Une enquête particulièrement minutieuse parue dans le journal Science suspecte une fraude sur un article publié en 2006 dans Nature. © freshidea, Fotolia

Alzheimer’s: does the suspected fraud challenge our knowledge of the disease?

Share it

You will also be interested


[EN VIDÉO] Soon a blood test to detect Alzheimer’s disease?
A blood test to detect Alzheimer’s disease that could be done at your doctor’s office would soon be possible.

For more than two decades, clinical research on Alzheimer’s disease has produced many therapeutic impasses. Some see this as a refutation of the amyloid hypothesis. Yet this hypothesis has dominated Alzheimer’s research for a long time. Although controversial, there is strong evidence to consider it scientifically valid. But here it isa particularly meticulous investigation published in the newspaper Science suspected fraud on an article published in 2006 in Nature. The latter is extremely cited in research on Alzheimer’s. Beyond the ongoing investigation, the investigation suggests that this fraud could undermine the amyloid hypothesis. According to Jean-Charles Lambert, research director at Inserm, neuroscientist specializing in Alzheimer’s disease at the University Hospital of Lille, this is not the case.

A media frenzy

To fully understand what is happening, it is necessary to specify the content of the article which is the subject of suspicion of fraud. The latter intends to demonstrate the existence of a oligomer of protein Synthesis of…” data-image=”https://cdn.futura-sciences.com/buildsv6/images/midioriginal/c/2/1/c21d283fdf_50038231_plaques-seniles-amyloid-nephron-wiki-cc -30.jpg” data-url=”https://news.google.com/health/definitions/biology-amyloid-plaque-11751/” data-more=”Read more”>beta-amyloid which would be associated with cognitive decline in the animal model: the amyloid beta protein *56 (AB*56), in accordance with its mass molecular weight of 56 kilo Daltons. It is therefore not the heart of what supports the amyloid hypothesis that is called into question but an additional hypothesis, on one of the oligomers of this protein.

But what is the difference? If this article has been cited often, that suggests it was influential, and articles that relied on these results are also good to throw away. This is when you have to take a step back. Jean-Charles Lambert, who is familiar with the literature on Alzheimer’s disease, discusses the reasons why this article is highly cited: ” It is a pioneering paper in research on toxic oligomers of amyloid proteins and it is above all for this purpose that it is cited by other research teams”.

Not so influential results

This is important because it is not so much the methodology as the results that are suspected to be fraudulent: Western Blot images (a biotechnology to separate and identify the proteins of a sample) would have been tampered with to stick to the initial hypothesis. Yet, as Jean-Charles Lambert points out, “ no one has succeeded in reproducing the results for the AB*56 protein. From then on, the results were no longer taken seriously by the scientific community.”

What must be understood is that the AB*56 protein is not the only oligomer studied in the pathogenicity of Alzheimer’s disease. There are others and the fact that the results concerning an oligomer are potentially fraudulent does not imply that the others are also. Therefore, it even less implies the fallacy of the amyloid hypothesis. On the other hand, the researchers now better understand why no one was able to replicate the results concerning this oligomer.

Financing risks

If this excitement is misunderstood by the general public and by the body politic, it could lead to less funding, in an area that is already suffering from a lack of resources. Indeed, according to a recent Senate report, research in biology and health appears underfunded in comparison with the majority of developed countries. The amyloid hypothesis is certainly not untouchable. We already have expressed doubts about him on Futura and consider alternative hypotheses. However, you should not seize bad arguments and preach for your theoretical parish. If the amyloid hypothesis is false, (honest) scientific work will take care of demonstrating it.

What you must remember

  • Suspicion of fraud affects several research articles concerning Alzheimer’s disease;
  • These articles were influential for their methodologies and not for their results;
  • Therefore, the potential fraud, as serious as it is, does not call into question the amyloid hypothesis.

A desire to escape for the summer?

To celebrate the holidays as it should be, discover the Mag Futura at the preferential price of €15 instead of €19, i.e. a reduction of 20% !

On the program of this issue: a dive into the heart of 4 scientific themes that will mark 2022, from the Earth to the Moon:

  • What mysteries does the Moon still hide from us?
  • Will we soon be able to cure everything thanks to genes?
  • How to feed the world without destroying it?
  • Can artificial intelligence become truly intelligent?

What is Mag Futura?

  • Our first paper journal of more than 200 pages to make science accessible to as many people as possible
  • 4 major scientific questions for 2022, from the Earth to the Moon
  • Home delivery*

*Delivery is made in France (excluding metropolitan France), Switzerland, Belgium.

Interested in what you just read?

#Alzheimers #suspected #fraud #challenge #knowledge #disease


Share it